Hap Trading, LLC Sellas Life Sciences Group, Inc. Put Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.38 $18,584 - $31,096	-9,200 Reduced 47.92%	10,000 $53,000
Q2 2022 Aug 12, 2022	BUY	$2.14 - $4.15 $1,070 - $2,075	500 Added 2.67%	19,200 $100,000
Q1 2022 May 12, 2022	BUY	$4.73 - $7.18 $88,451 - $134,266	18,700 New	18,700 $42,000
Q2 2021 Aug 11, 2021	SELL	$7.19 - $13.71 $84,842 - $161,778	-11,800 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.5 - $11.71 $64,900 - $138,178	11,800 New	11,800 $14,000

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $19.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.